Raymond Townsend
Nephrology · Philadelphia, PANPI 1497786321
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Medtronic at 49.8% of the total. 2025 is the largest year on record at $106,090, more than ten times the $7,412 reported in 2019. Among nephrology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 399 payments — averaging $893.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$178K
- Astrazeneca UK Limited$67K
- AstraZeneca$28K
- Bard Peripheral Vascular, Inc.$27K
- Corcept Therapeutics$17K
- Johnson & Johnson$14K
- plus $26K from 9 others
Across 8 payments — averaging $7094.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$57K
What the payments were for
- Consulting fees$179,99850%
- Speaking & faculty fees$108,60830%
- Grants$1,5000%
- Travel & lodging$60,33917%
- Food & beverage$6,1092%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 259 | $177,735 |
| Astrazeneca UK Limited | 30 | $67,035 |
| AstraZeneca | 21 | $27,997 |
| Bard Peripheral Vascular, Inc. | 13 | $26,950 |
| Corcept Therapeutics | 17 | $17,084 |
| Johnson & Johnson | 28 | $14,236 |
| Fukuda Denshi Co., Ltd.(2 entities) | 11 | $9,678 |
| Regeneron | 5 | $5,820 |
| Jazz Pharmaceuticals Inc. | 9 | $5,129 |
| Idorsia Pharmaceuticals US Inc | 1 | $2,820 |
| Janssen Global Services, LLC | 1 | $1,800 |
| Bayer | 1 | $115 |
| Calliditas Therapeutics US Inc. | 1 | $104 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Boehringer Ingelheim International GmbH | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$356,553 in reported general payments places this provider in the 95th percentile of 586 nephrology providers in Pennsylvania.
Other nephrology in Philadelphia
- Rakesh GulatiPhiladelphia$657K
- Ellie KelepourisPhiladelphia$287K
- Abdallahsassine GearaPhiladelphia$225K
- Katalin SusztakPhiladelphia$192K
- Debbie Cohen SteinPhiladelphia$112K
- Laura DemberPhiladelphia$110K
- Jonathan HoganPhiladelphia$100K
- Michael YoslovPhiladelphia$79K
- Michael LevinPhiladelphia$55K
- Gaia MuallemPhiladelphia$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.